Stanford University School of Medicine
Stanford, California, 94305, United States
NCT Number: NCT01135719
Subjects with myopia, hyperopia and astigmatism are being randomized to be treated in one eye with a wavefront-guided excimer laser and their fellow eye treated with a wavefront-optimized excimer laser.
Looking for future studies?
Notify Me21 year–60 year
All sexes
Interventional
Not applicable
Stanford, California, 94305, United States
Subjects with myopia, hyperopia and astigmatism are being randomized by ocular dominance to be treated with either PRK or LASIK. One eye will be treated with a wavefront-guided excimer laser and the fellow eye will be treated with a wavefront optimized excimer laser.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Autoimmune diseases.
Wavefront-guided versus wavefront-optimized LASIK or PRK.
Other names: Allegretto Wave Eye-Q 400 Hz excimer laser, Visx CustomVue excimer laser, Laser in-situ keratomileusis, Photorefractive keratectomy, Wavefront-guided, Wavefront-optimized
Time frame: One year
Time frame: One year
Time frame: One year
Time frame: One year
Time frame: One year
Time frame: One year
Edward E. Manche
Other
A Prospective Randomized Comparison of Fellow Eyes Undergoing LASIK or PRK With a Wavefront-guided Excimer Laser Versus a Wavefront-optimized Excimer Laser
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06873048
Astigmatism, Eye Diseases
Waterloo, Ontario, Canada
View Trial DetailsNCT07291739
Astigmatism, Eye Diseases
Makati City, Philippines
View Trial DetailsNCT05959200
Ametropia, Astigmatism
Oakland, California, United States
View Trial DetailsNCT04820218
Astigmatism, Eye Diseases
Newark, California, United States
View Trial Details